Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by HOWE, G R
Right arrow Articles by MILLER, A B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HOWE, G R
Right arrow Articles by MILLER, A B
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1979 Oxford University Press

research-article

Isoniazid Exposure in Relation to Cancer Incidence and Mortality in a Cohort of Tuberculosis Patients

G R HOWE1, J LINDSAY2, E COPPOCK3 and A B MILLER4

1,4 N. C.I.C. Epidemiology Unit, Faculty of Medicine, McMurrich Building, University of Toronto Toronto, Ontario, M5S 1A8, Canada
2 Vital Statistics and Disease Registries Section, Health Division, Statistics Canada Ottawa, Ontario, Canada
3 Systems Development Division, Statistics Canada, Ottawa, Ontario, Canada.

Howe G R [NCIC Epidemiology Unit, Faculty of Medicine, McMurrich Building, University of Toronto, Toronto, Ontario M5S 1A8, Canada), Lindsay J, Coppock E and Miller A B. Isoniazid exposure in relation to cancer incidence and mortality in a cohort of tuberculosis patients. International Journal of Epidemiology 1979, 8: 305–312.

41 226 isoniazid exposed and 22 811 non-exposed patients admitted to Canadian institutions for the treatment of tuberculosis from 1952 to 1960 were followed to 1973 by computerised record linkage to the National Death Index and, for 1969 to 1973, to the National Cancer Incidence Reporting System. The mortality for the total cohort compared to that expected from the mortality in the Canadian population, was greater than expected for tuberculosis, other chest diseases and certain cancer sites associated with cigarette smoking (except bladder cancer). There was, however, no difference between the isoniazid-exposed and non-exposed in mortality from all cancer and individual cancer sites, except for oesophageal cancer in males. Cancer incidence from 1969 to 1973 was also similar for the isoniazid- exposed and non-exposed groups. An elevated standardised incidence ratio was seen only for buccal cavity and pharynx in male exposed subjects. It is concluded that this study provides additional negative evidence on the carcinogenicity of isoniazid in man.

Revised 8 August 1979


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int J EpidemiolHome page
A. V Brenner, Z. Wang, R. A Kleinerman, L. Wang, S. Zhang, C. Metayer, K. Chen, S. Lei, H. Cui, and J. H Lubin
Previous pulmonary diseases and risk of lung cancer in Gansu Province, China
Int. J. Epidemiol., February 1, 2001; 30(1): 118 - 124.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.